Etiology, symptomatology, and diagnosis of uterine myomas.
about
Danazol for uterine fibroidsDanazol for uterine fibroidsProceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendationsHigh aromatase expression in uterine leiomyoma tissues of African-American womenEpidemiology of Uterine Myomas: A ReviewLearning about the Importance of Mutation Prevention from Curable Cancers and Benign TumorsMagnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.Medical treatment of uterine leiomyomaMutations in Exon 1 highlight the role of MED12 in uterine leiomyomasA Split-and-Merge-Based Uterine Fibroid Ultrasound Image Segmentation Method in HIFU Therapy.No evidence for the role of somatic mutations and promoter hypermethylation of FH gene in the tumorigenesis of nonsyndromic uterine leiomyomas.Uterine fibroids: current perspectivesMRgFUS treatment of uterine fibroid in a nulliparous woman with acute retention of urinePrevalence of uterine myomas in women in Germany: data of an epidemiological study.Symptoms of uterine myomas: data of an epidemiological study in Germany.Increased risk of breast cancer in women with uterine myoma: a nationwide, population-based, case-control study.Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroidsThe use of mifepristone in abortion associated with an increased risk of uterine leiomyomasFemale Reproductive Factors and Differentiated Thyroid Cancer.Pregnancy and natural delivery following magnetic resonance imaging-guided focused ultrasound surgery of uterine myomasMice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndromeThe role of TWIST, SERPINB5, and SERPIN1 genes in uterine leiomyomas.Recent Advances in Uterine Fibroid Etiology.Progesterone is essential for maintenance and growth of uterine leiomyoma.Receptors of hypothalamic-pituitary-ovarian-axis hormone in uterine myomasAdvances in the management of uterine fibroidsMED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.Molecular genetics and racial disparities of uterine leiomyomasRole of stem cells in human uterine leiomyoma growth.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.The genetic bases of uterine fibroids; a review.Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.Role of nuclear progesterone receptor isoforms in uterine pathophysiology.The association between subclinical atherosclerosis and uterine fibroids.Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study.Presentation and treatment of uterine leiomyoma in adolescence: a systematic review.Do symptomatic endometriosis and uterine fibroids appear together?Uterine leiomyoma and its association with menstrual pattern and history of depo-medroxyprogesterone acetate injections.Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus.
P2860
Q24239837-C4DFE5E8-2072-4626-A807-E618E72FB752Q24240341-5F012219-BBD5-4DCE-838F-721A199FDE1AQ24567733-EE72BF55-4E92-4ED2-8C63-23DC8DE8FF14Q24658231-719888A0-5907-4CAF-B619-21B485FB881EQ26764887-C1817EE0-B99A-477F-B696-BCB482FBB813Q26766238-B028E8F6-305B-4B3F-A64D-38CC86FCA3A7Q26781819-E7AB3CC8-80A7-4B3E-9904-C1FABF3D1204Q26824379-51D48F37-D306-4F10-AD2B-245E09DF93B2Q28243075-D9F363A1-176B-43B4-A14D-6E5F68C7A8AAQ30410956-B84BBB64-668A-4A26-AB88-BEE66FB187F7Q30415944-F095C266-FF43-4248-8B36-F65AD3443E7CQ30443242-B8C5EFAB-AE97-42DA-8D0C-B5A165B473BAQ30466724-A0A1B862-35F3-43CD-A7DB-FA8EF6E6B418Q31015107-6C547637-EAA3-4931-A6BE-A5666B509480Q31143892-01212039-14A5-496D-9589-DD7F7450681EQ33563943-411770B2-9CE2-43DB-9AE7-2A9CAB567D8DQ33598604-8FE42DB2-2A02-47D6-9F61-C42BB904A572Q33627092-01AD510A-7C2D-4DB1-8492-6BF5BA4B0E73Q33715432-9396D7EF-40F6-4475-97E2-E1E3A8C2C848Q33781993-5165397A-98F3-4BF3-9009-76F92F9679AAQ33803018-F4F62075-F521-45EB-9C85-269A7B8662CEQ33811879-1A1E0E6E-6A8F-4D2A-98CD-ADF9BD1DBCF1Q33852886-8138F056-76F4-4D24-991F-8AB488362A7CQ33874391-BD5EAA26-AFF1-40B2-988C-6D976BC1047CQ33876546-9D216D30-18B4-4952-AE16-55FFAF58CAB2Q34167409-C26CAA45-4ACF-4A15-BFF8-6B08574222ECQ34210977-CE628DFC-FBFD-4123-B401-2815FF985D53Q34228266-B4670F77-E47F-46E7-ABCA-57E10F0D3AF4Q34263429-22B00F5B-4672-4051-976F-2837208CC751Q34321877-541C2977-8C2A-4DF4-96C9-65AB7FD112E4Q34362689-1F746AB9-4E6E-4261-B25A-0C87ABCDEB8BQ34437666-B32BCB20-CC07-41B5-B10C-6589B4E4F691Q34448400-DE8B3C8D-21C6-4FC2-A51F-9C9F15E29F89Q34603011-10F9F710-092F-460E-BD35-11329F481D67Q34674982-9BC9B50C-FB6E-4D60-A661-AA70FB6D7C96Q34965833-A0E34ACF-6D94-4364-813B-E88D2191BC1EQ35021066-2A83742A-FEDD-4450-A3F8-7D8465B4DDCDQ35104500-333F066E-D4CE-4103-B7E9-1D3B10840B94Q35147224-6D3A6C92-DB12-4493-8939-299B858D9D7AQ35551056-7AD1BFE5-3014-4775-9B5F-C620BDA651AA
P2860
Etiology, symptomatology, and diagnosis of uterine myomas.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Etiology, symptomatology, and diagnosis of uterine myomas.
@ast
Etiology, symptomatology, and diagnosis of uterine myomas.
@en
type
label
Etiology, symptomatology, and diagnosis of uterine myomas.
@ast
Etiology, symptomatology, and diagnosis of uterine myomas.
@en
prefLabel
Etiology, symptomatology, and diagnosis of uterine myomas.
@ast
Etiology, symptomatology, and diagnosis of uterine myomas.
@en
P1476
Etiology, symptomatology, and diagnosis of uterine myomas.
@en
P2093
William H Parker
P304
P356
10.1016/J.FERTNSTERT.2007.01.093
P407
P577
2007-04-01T00:00:00Z